Compounds > etoposide phosphate

etoposide phosphate and Neoplasms

etoposide phosphate has been researched along with Neoplasms in 17 studies

Research

Studies (17)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	14 (82.35)	18.2507
2000's	2 (11.76)	29.6817
2010's	1 (5.88)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kokache, A; Mahmoud, S; Sambasivan, K; Savage, P; Seckl, M	1
Aubin, F; Burgot, G; Gandemer, V; Le Gall, E; Marigny, K	1
Collier, K; How, K; Savage, P; Schink, C; Seckl, M; Young, AM	1
Bukowski, R; Fields, SZ; Gandara, D; Goss, G; Igwemezie, LN; Kaul, S; Kosty, M; Levithan, N; O'Dwyer, P; Stewart, DJ	1
Barbhaiya, RH; Garrow, C; Greco, A; Hainsworth, JD; Igwenezue, KB; Kaul, S; Miller, AA; Schacter, LP; Srinivas, NR; Thompson, DS	1
Cavalli, F; Cerny, T; De Fusco, M; De Jong, J; Gentili, D; McDaniel, C; Pagani, O; Prins, C; Sessa, C; Zucchetti, M	1
Albert, E; Igwemezie, LN; Morgenthien, E; Randolph, J; Santabárbara, P; Schacter, LP; Seyedsadr, M	1
Allen, SL; Behr, J; Budman, DR; Hock, K; Igwemezie, LN; Kaul, S; Kolitz, J; Lichtman, S; Schulman, P; Vinciguerra, V	1
Balmanno, K; Chapman, F; Charlton, CJ; Gumbrell, L; Igwemezie, LN; Lind, MJ; Millward, MJ; Mummaneni, V; Newell, DR; Proctor, M	1
Baer, J; Budman, DR; Fields, SZ; Hock, K; Ingram, R; Kreis, W; Schacter, LP; Vinciguerra, V	1
Abigerges, D; Armand, JP; Bonnay, M; Chabot, GG; de Forni, M; Igwemezie, L; Kaul, S; Ropers, J; Schacter, L; Terret, C; Winograd, B	1
Alberts, DS; Barbhaiya, RH; Brooks, DJ; Igwemzie, LM; Kaul, S; McKinney, LM; Randolph, J; Schacter, L; Srinivas, NR; Thomas, T	1
Behr, J; Budman, DR; Cherny, RC; Fields, SZ; Ingram, R; Kreis, W; Schacter, LP; Schulman, P; Snow, C; Wright, J; Young, RR	1
Barbhaiya, RH; Calvert, AH; Igwemezie, LN; Kaul, S; Mummaneni, V; Newell, DR; Porter, D; Thomas, H; Winograd, B	1
Creaven, PJ; Gunton, KE; Meropol, NJ; Noel, D; Pendyala, L; Schacter, LP; Soni, N	1
Greco, FA; Hainsworth, JD; Utley, SM	1
Barbhaiya, RH; Fields, SZ; Himpler, BS; Igwemezie, LN; Kaul, S; Litam, PP; McAleer, C; Schacter, LP; Schilder, RJ; Wright, J	1

Trials

14 trial(s) available for etoposide phosphate and Neoplasms

Article	Year
Pharmacokinetics and bioequivalence of etoposide following intravenous administration of etoposide phosphate and etoposide in patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:11 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents; Biological Availability; Chromatography, High Pressure Liquid; Drug Administration Schedule; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Therapeutic Equivalency	1995
A phase I study of etoposide phosphate administered as a daily 30-minute infusion for 5 days. Clinical pharmacology and therapeutics, 1995, Volume: 57, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Chromatography, High Pressure Liquid; Cohort Studies; Dose-Response Relationship, Drug; Etoposide; Female; Half-Life; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds	1995
Phase I clinical and pharmacokinetic study of oral etoposide phosphate. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1995, Volume: 13, Issue:1 Topics: Administration, Oral; Adult; Aged; Analysis of Variance; Biological Availability; Drug Administration Schedule; Etoposide; Humans; Injections, Intravenous; Lymphoma; Middle Aged; Models, Biological; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs	1995
Clinical and pharmacokinetic overview of parenteral etoposide phosphate. Cancer chemotherapy and pharmacology, 1994, Volume: 34 Suppl Topics: Animals; Blood Pressure; Drug Administration Schedule; Etoposide; Humans; Infusions, Intravenous; Leukocyte Count; Neoplasms; Organophosphorus Compounds	1994
Phase I evaluation of a water-soluble etoposide prodrug, etoposide phosphate, given as a 5-minute infusion on days 1, 3, and 5 in patients with solid tumors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1994, Volume: 12, Issue:9 Topics: Adult; Aged; Alopecia; Chromatography, High Pressure Liquid; Drug Administration Schedule; Etoposide; Feasibility Studies; Female; Half-Life; Humans; Infusions, Intravenous; Male; Middle Aged; Nausea; Neoplasms; Neutropenia; Organophosphorus Compounds; Prodrugs; Regression Analysis; Solubility; Vomiting	1994
Phase I and pharmacokinetic study of a water-soluble etoposide prodrug, etoposide phosphate (BMY-40481). European journal of cancer (Oxford, England : 1990), 1995, Volume: 31A, Issue:13-14 Topics: Adult; Aged; Antineoplastic Agents; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Female; Humans; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Ovarian Neoplasms; Prodrugs	1995
Pharmacokinetic evaluation of high-dose etoposide phosphate after a 2-hour infusion in patients with solid tumors. Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:4 Topics: Antineoplastic Agents; Etoposide; Female; Half-Life; Humans; Infusions, Intravenous; Linear Models; Male; Metabolic Clearance Rate; Neoplasms; Organophosphorus Compounds	1996
Etoposide bioavailability after oral administration of the prodrug etoposide phosphate in cancer patients during a phase I study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1996, Volume: 14, Issue:7 Topics: Administration, Oral; Adolescent; Adult; Aged; Antineoplastic Agents; Biological Availability; Chromatography, High Pressure Liquid; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Prodrugs	1996
Phase I and pharmacokinetic study of etoposide phosphate. Anti-cancer drugs, 1995, Volume: 6, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Diarrhea; Dose-Response Relationship, Drug; Etoposide; Humans; Middle Aged; Neoplasms; Organophosphorus Compounds; Regression Analysis; Thrombocytopenia	1995
Phase I study of high-dose etoposide phosphate in man. Bone marrow transplantation, 1996, Volume: 18, Issue:5 Topics: Adult; Aged; Antineoplastic Agents; Bone Marrow Transplantation; Combined Modality Therapy; Etoposide; Female; Humans; Infusions, Intravenous; Injections, Subcutaneous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds	1996
Bioequivalence assessment of etoposide phosphate and etoposide using pharmacodynamic and traditional pharmacokinetic parameters. Journal of pharmacokinetics and biopharmaceutics, 1996, Volume: 24, Issue:4 Topics: Adult; Aged; Analysis of Variance; Antineoplastic Agents, Phytogenic; Cross-Over Studies; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Prodrugs; Therapeutic Equivalency	1996
Phase I and pharmacokinetic study of etoposide phosphate by protracted venous infusion in patients with advanced cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1997, Volume: 15, Issue:2 Topics: Adult; Aged; Ambulatory Care; Antineoplastic Agents; Biological Availability; Etoposide; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Treatment Outcome	1997
Phase I study of high dose etoposide phosphatase with filgrastim (G-CSF) in the treatment of advanced refractory malignancies. Investigational new drugs, 1997, Volume: 15, Issue:4 Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Bone Marrow Diseases; Drug Resistance, Neoplasm; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Leukocyte Count; Male; Middle Aged; Neoplasms; Organophosphorus Compounds; Platelet Count; Recombinant Proteins	1997
Phase I study of etoposide phosphate (etopophos) as a 30-minute infusion on days 1, 3, and 5. Clinical cancer research : an official journal of the American Association for Cancer Research, 1995, Volume: 1, Issue:1 Topics: Adult; Aged; Antineoplastic Agents; Dose-Response Relationship, Drug; Drug Administration Schedule; Etoposide; Female; Half-Life; Hemoglobins; Humans; Infusions, Intravenous; Leukopenia; Male; Metabolic Clearance Rate; Middle Aged; Neoplasms; Organophosphorus Compounds; Thrombocytopenia	1995

Other Studies

3 other study(ies) available for etoposide phosphate and Neoplasms

Article	Year
Hypersensitivity reactions to etoposide phosphate. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2014, Volume: 20, Issue:2 Topics: Adult; Antineoplastic Agents; Drug Hypersensitivity; Etoposide; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Organophosphorus Compounds; Young Adult	2014
Particular cutaneous side effects with etoposide-containing courses: is VP16 or etoposide phosphate responsible? Cancer chemotherapy and pharmacology, 2005, Volume: 55, Issue:3 Topics: Adolescent; Anal Canal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Etoposide; Fingers; Humans; Infant; Infant, Newborn; Neoplasms; Organophosphorus Compounds; Retrospective Studies; Skin Diseases; Toes	2005
Successful treatment with etoposide phosphate in patients with previous etoposide hypersensitivity. Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2008, Volume: 14, Issue:1 Topics: Adolescent; Adult; Aged; Anti-Allergic Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Chlorpheniramine; Drug Hypersensitivity; Etoposide; Female; Humans; Hydrocortisone; Infusions, Intravenous; Male; Middle Aged; Neoplasms; Organophosphorus Compounds	2008